The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

NCT06150144 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Basal Cell Carcinoma
BCC

Interventions

DRUG: 5-Fluorouracil
OTHER: SURGERY

Sponsor

University of Aleppo

Collaborators

[object Object]